Concepedia

Author

Eiji Torikai

Hamamatsu University School of Medicine

Also Known As

E Torikai, E. Torikai, Eiji Torikai

37

Publications

561

Citations

14

H-Index

40

Concepts

All Affiliations

Hamamatsu University School of MedicineHamamatsu University
ET

About

Eiji Torikai is an author at Hamamatsu University School of Medicine specializing in rheumatoid arthritis, medicine, and rheumatology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

480

2

Immunology

9

9

395

3

Orthopaedics

3

3

38

4

Health Sciences

2

2

36

5

Diagnostic Sciences

1

1

14

Eiji Torikai

×

16

Publications

524

Citations

14

H-Index

YearCitations

Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis.

Yasunori Kageyama, M Takahashi, Tetsuya Ichikawa,

PubMed

2008

74

Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis

Yasunori Kageyama, Masaaki Takahashi, Tetsuyuki Nagafusa,

Rheumatology International

2007

69

Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis

Yasunori Kageyama, Tetsuya Ichikawa, Tetsuyuki Nagafusa,

Rheumatology International

2007

67

Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33

Yasunori Kageyama, Eiji Torikai, Kunio Tsujimura,

Modern Rheumatology

2011

40

Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis

Yasunori Kageyama, Eiji Torikai, Akira Nagano

Rheumatology International

2006

36

Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33

Yasunori Kageyama, Eiji Torikai, Kunio Tsujimura

Modern Rheumatology

2012

36

The effect of infliximab on bone metabolism markers in patients with rheumatoid arthritis

Eiji Torikai, Yasunori Kageyama, Masaaki Takahashi,

Lara D. Veeken

2006

34

Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

Yasunori Kageyama, Masaaki Takahashi, Eiji Torikai,

Clinical Rheumatology

2006

31

The effect of infliximab on chemokines in patients with rheumatoid arthritis

Eiji Torikai, Yasunori Kageyama, Motohiro Suzuki,

Clinical Rheumatology

2006

28

The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis

Eiji Torikai, Yasunori Kageyama, Masaaki Takahashi,

Modern Rheumatology

2006

25

Page 1